These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 758468)

  • 1. First-pass effect after rectal administration of thiazinamium methylsulfate.
    Jonkman JH; van Bork LE; Wijsbeek J; Bolhuis-de Vries AS; de Zeeuw RA; Orie NG; Cox HL
    J Pharm Sci; 1979 Jan; 68(1):69-72. PubMed ID: 758468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. II. Oral and rectal administration.
    Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG
    Pharm Weekbl Sci; 1982 Oct; 4(5):129-34. PubMed ID: 6128714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in the bioavailability of thiazinamium methylsulfate.
    Jonkman JH; Van Bork LE; Wijsbeek J; De Zeeuw RK; Orie NG
    Clin Pharmacol Ther; 1977 Apr; 21(4):457-63. PubMed ID: 849677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.
    Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG; Soeterboek AM; Bender J
    Pharm Weekbl Sci; 1982 Oct; 4(5):122-8. PubMed ID: 6128713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "First pass effect" after rectal administration of thiazinamium methylsulphate [proceedings].
    Jonkman JH; van Bork LE; Wijsbeek J; de Zeeuw RA; Orie NG; Cox HL
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():56P. PubMed ID: 12333
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic first-pass effect of thiazinamium methylsulfate (N-methylpromethazine methylsulfate) in dogs.
    Jonkman JH; Westenberg HG; Van Der Kleyn E
    J Pharm Sci; 1981 Aug; 70(8):947-9. PubMed ID: 6118426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability after intramuscular injection.
    Jonkman JH; van Bork LE; de Zeeuw RA; Orie NG
    Lancet; 1976 Mar; 1(7961):693. PubMed ID: 73664
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Bioavailability of the quaternary ammonium compound thiazinamium methylsulphate (Multergan) after oral and intramuscular administration.
    Jonkman JH; Wijsbeek U; Brouwer SH; De Zeeuw RA
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():63P. PubMed ID: 4156742
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the bioavailability of oral, rectal and intramuscular promethazine.
    Schwinghammer TL; Juhl RP; Dittert LW; Melethil SK; Kroboth FJ; Chung VS
    Biopharm Drug Dispos; 1984; 5(2):185-94. PubMed ID: 6743785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
    Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
    Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic disposition and biliary excretion of the organic cations thiazinamium and thiazinamium sulfoxide in rats.
    Neef K; Jonkman JH; Meijer DK
    J Pharm Sci; 1978 Aug; 67(8):1147-50. PubMed ID: 671255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic and therapeutic use of thiazinamium (Multergan)].
    van Bork LE; Jonkman JH; de Zeeuw RA; Orie NG; Peset R; de Vries K
    Ned Tijdschr Geneeskd; 1977 Jul; 121(30):1196-202. PubMed ID: 887179
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacokinetics of intramuscular thiazinamium methyl sulfate.
    Jonkman JH; Van Bork LE; Calvert B; Greving JE; Wijsbeek J; De Zeeuw RA; Orie NG
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):454-9. PubMed ID: 6138313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole body distribution of the quaternary ammonium compound thiazinamium (N-methylpromethazine) and promethazine in monkey and mice.
    Jonkman JH; Westenberg HG; Rijntjes NV; van der Kleijn E; Lindeboom SF
    Arzneimittelforschung; 1983; 33(2):223-8. PubMed ID: 6133524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative bronchodilator properties of alkyl quaternary salts of promethazine.
    Lewis AJ; Dervinis A; Rosenthale ME; Santilli AA; Buzby GC
    Int Arch Allergy Appl Immunol; 1984; 75(3):282-3. PubMed ID: 6148311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal drug administration: clinical pharmacokinetic considerations.
    de Boer AG; Moolenaar F; de Leede LG; Breimer DD
    Clin Pharmacokinet; 1982; 7(4):285-311. PubMed ID: 6126289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral and rectal nalbuphine bioavailability: first-pass metabolism in rats and dogs.
    Aungst BJ; Lam G; Shefter E
    Biopharm Drug Dispos; 1985; 6(4):413-21. PubMed ID: 4084666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of low cencentrations of the quaternary ammonium compound thiazinamium methylsulphate in plasma and urine.
    Jonkman JG; Wijsbeek J; Hollenbeek S; de Boer SH; de Zeeuw RA; Van Bork LE; Orie NG
    J Pharm Pharmacol; 1975 Nov; 27(11):849-54. PubMed ID: 1494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patients.
    Holford NH; Clements P; Collier P; Orie NG; van Bork LE; Jonkman JH
    Eur J Clin Pharmacol; 1987; 33(3):237-42. PubMed ID: 2891535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration.
    Heykants J; Hendriks R; Meuldermans W; Michiels M; Scheygrond H; Reyntjens H
    Eur J Drug Metab Pharmacokinet; 1981; 6(1):61-70. PubMed ID: 7250152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.